| UniProt ID | RS13_HUMAN | |
|---|---|---|
| UniProt AC | P62277 | |
| Protein Name | 40S ribosomal protein S13 | |
| Gene Name | RPS13 | |
| Organism | Homo sapiens (Human). | |
| Sequence Length | 151 | |
| Subcellular Localization | ||
| Protein Description | ||
| Protein Sequence | MGRMHAPGKGLSQSALPYRRSVPTWLKLTSDDVKEQIYKLAKKGLTPSQIGVILRDSHGVAQVRFVTGNKILRILKSKGLAPDLPEDLYHLIKKAVAVRKHLERNRKDKDAKFRLILIESRIHRLARYYKTKRVLPPNWKYESSTASALVA | |
| Overview of Protein Modification Sites with Functional and Structural Information | ||
|
|
||
* ASA = Accessible Surface Area
| Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
|---|---|---|---|---|---|
| 9 | 2-Hydroxyisobutyrylation | GRMHAPGKGLSQSAL CCCCCCCCCCCCCCC | 56.47 | - | |
| 9 | Ubiquitination | GRMHAPGKGLSQSAL CCCCCCCCCCCCCCC | 56.47 | 23000965 | |
| 9 | Acetylation | GRMHAPGKGLSQSAL CCCCCCCCCCCCCCC | 56.47 | 26051181 | |
| 12 | Phosphorylation | HAPGKGLSQSALPYR CCCCCCCCCCCCCCC | 30.66 | 21712546 | |
| 14 | Phosphorylation | PGKGLSQSALPYRRS CCCCCCCCCCCCCCC | 28.53 | 30108239 | |
| 18 | Phosphorylation | LSQSALPYRRSVPTW CCCCCCCCCCCCCCE | 21.36 | 28152594 | |
| 21 | Phosphorylation | SALPYRRSVPTWLKL CCCCCCCCCCCEEEC | 24.37 | 20068231 | |
| 24 | Phosphorylation | PYRRSVPTWLKLTSD CCCCCCCCEEECCCH | 41.07 | 20068231 | |
| 27 | Succinylation | RSVPTWLKLTSDDVK CCCCCEEECCCHHHH | 41.08 | - | |
| 27 | Succinylation | RSVPTWLKLTSDDVK CCCCCEEECCCHHHH | 41.08 | 21890473 | |
| 27 | Ubiquitination | RSVPTWLKLTSDDVK CCCCCEEECCCHHHH | 41.08 | 27667366 | |
| 27 | 2-Hydroxyisobutyrylation | RSVPTWLKLTSDDVK CCCCCEEECCCHHHH | 41.08 | - | |
| 27 | Acetylation | RSVPTWLKLTSDDVK CCCCCEEECCCHHHH | 41.08 | 19608861 | |
| 29 | Phosphorylation | VPTWLKLTSDDVKEQ CCCEEECCCHHHHHH | 28.64 | 19691289 | |
| 30 | Phosphorylation | PTWLKLTSDDVKEQI CCEEECCCHHHHHHH | 42.10 | 19691289 | |
| 34 | Ubiquitination | KLTSDDVKEQIYKLA ECCCHHHHHHHHHHH | 51.39 | 23000965 | |
| 34 | Succinylation | KLTSDDVKEQIYKLA ECCCHHHHHHHHHHH | 51.39 | - | |
| 34 | Succinylation | KLTSDDVKEQIYKLA ECCCHHHHHHHHHHH | 51.39 | 23954790 | |
| 34 | Acetylation | KLTSDDVKEQIYKLA ECCCHHHHHHHHHHH | 51.39 | 25825284 | |
| 38 | Phosphorylation | DDVKEQIYKLAKKGL HHHHHHHHHHHHCCC | 10.31 | 27155012 | |
| 39 | Acetylation | DVKEQIYKLAKKGLT HHHHHHHHHHHCCCC | 43.53 | 23749302 | |
| 39 | Ubiquitination | DVKEQIYKLAKKGLT HHHHHHHHHHHCCCC | 43.53 | 23000965 | |
| 39 | Malonylation | DVKEQIYKLAKKGLT HHHHHHHHHHHCCCC | 43.53 | 26320211 | |
| 42 | Ubiquitination | EQIYKLAKKGLTPSQ HHHHHHHHCCCCHHH | 58.78 | 23000965 | |
| 43 | Sumoylation | QIYKLAKKGLTPSQI HHHHHHHCCCCHHHH | 54.25 | 28112733 | |
| 43 | Malonylation | QIYKLAKKGLTPSQI HHHHHHHCCCCHHHH | 54.25 | 26320211 | |
| 43 | Ubiquitination | QIYKLAKKGLTPSQI HHHHHHHCCCCHHHH | 54.25 | 23000965 | |
| 43 | Acetylation | QIYKLAKKGLTPSQI HHHHHHHCCCCHHHH | 54.25 | 26051181 | |
| 46 | Phosphorylation | KLAKKGLTPSQIGVI HHHHCCCCHHHHEEE | 29.57 | - | |
| 48 | Phosphorylation | AKKGLTPSQIGVILR HHCCCCHHHHEEEEE | 29.24 | 28450419 | |
| 57 | Phosphorylation | IGVILRDSHGVAQVR HEEEEECCCCEEEEE | 18.73 | 20860994 | |
| 70 | Ubiquitination | VRFVTGNKILRILKS EEEEEHHHHHHHHHH | 44.45 | 23000965 | |
| 70 | 2-Hydroxyisobutyrylation | VRFVTGNKILRILKS EEEEEHHHHHHHHHH | 44.45 | - | |
| 76 | Ubiquitination | NKILRILKSKGLAPD HHHHHHHHHCCCCCC | 47.99 | 23000965 | |
| 78 | Ubiquitination | ILRILKSKGLAPDLP HHHHHHHCCCCCCCC | 57.25 | 23000965 | |
| 78 | 2-Hydroxyisobutyrylation | ILRILKSKGLAPDLP HHHHHHHCCCCCCCC | 57.25 | - | |
| 78 | Acetylation | ILRILKSKGLAPDLP HHHHHHHCCCCCCCC | 57.25 | 26051181 | |
| 89 | Phosphorylation | PDLPEDLYHLIKKAV CCCCHHHHHHHHHHH | 13.60 | - | |
| 93 | 2-Hydroxyisobutyrylation | EDLYHLIKKAVAVRK HHHHHHHHHHHHHHH | 40.83 | - | |
| 93 | Ubiquitination | EDLYHLIKKAVAVRK HHHHHHHHHHHHHHH | 40.83 | 21906983 | |
| 93 | Acetylation | EDLYHLIKKAVAVRK HHHHHHHHHHHHHHH | 40.83 | 26051181 | |
| 94 | Ubiquitination | DLYHLIKKAVAVRKH HHHHHHHHHHHHHHH | 40.89 | 22817900 | |
| 107 | Ubiquitination | KHLERNRKDKDAKFR HHHHHCCCCCCCCHH | 73.08 | 24816145 | |
| 109 | Ubiquitination | LERNRKDKDAKFRLI HHHCCCCCCCCHHHH | 63.72 | 24816145 | |
| 112 | 2-Hydroxyisobutyrylation | NRKDKDAKFRLILIE CCCCCCCCHHHHHHH | 40.94 | - | |
| 120 | Phosphorylation | FRLILIESRIHRLAR HHHHHHHHHHHHHHH | 29.55 | 21712546 | |
| 128 | Phosphorylation | RIHRLARYYKTKRVL HHHHHHHHHCCCCCC | 12.05 | 22817900 | |
| 129 | Phosphorylation | IHRLARYYKTKRVLP HHHHHHHHCCCCCCC | 13.46 | 17081983 | |
| 141 | Phosphorylation | VLPPNWKYESSTASA CCCCCCCCCCCCCHH | 16.80 | 28152594 | |
| 143 | Phosphorylation | PPNWKYESSTASALV CCCCCCCCCCCHHHC | 29.87 | 28152594 | |
| 144 | Phosphorylation | PNWKYESSTASALVA CCCCCCCCCCHHHCC | 18.95 | 28152594 | |
| 145 | Phosphorylation | NWKYESSTASALVA- CCCCCCCCCHHHCC- | 33.63 | 28152594 | |
| 147 | Phosphorylation | KYESSTASALVA--- CCCCCCCHHHCC--- | 23.40 | 28152594 |
| Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
|---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of RS13_HUMAN !! | ||||||
| Modified Location | Modified Residue | Modification | Function | Reference | ||
|---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of RS13_HUMAN !! | ||||||
* Distance = the distance between SAP position and PTM sites.
| Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
|---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of RS13_HUMAN !! | ||||||
| Kegg Disease | ||||||
|---|---|---|---|---|---|---|
| There are no disease associations of PTM sites. | ||||||
| OMIM Disease | ||||||
| There are no disease associations of PTM sites. | ||||||
| Kegg Drug | ||||||
| There are no disease associations of PTM sites. | ||||||
| DrugBank | ||||||
| There are no disease associations of PTM sites. | ||||||
loading...
| Acetylation | |
| Reference | PubMed |
| "Lysine acetylation targets protein complexes and co-regulates majorcellular functions."; Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,Olsen J.V., Mann M.; Science 325:834-840(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-27 AND LYS-39, AND MASSSPECTROMETRY. | |
| Phosphorylation | |
| Reference | PubMed |
| "Kinase-selective enrichment enables quantitative phosphoproteomics ofthe kinome across the cell cycle."; Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,Greff Z., Keri G., Stemmann O., Mann M.; Mol. Cell 31:438-448(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-12, AND MASSSPECTROMETRY. | |
| "Automated phosphoproteome analysis for cultured cancer cells by two-dimensional nanoLC-MS using a calcined titania/C18 biphasic column."; Imami K., Sugiyama N., Kyono Y., Tomita M., Ishihama Y.; Anal. Sci. 24:161-166(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-30, AND MASSSPECTROMETRY. | |
| "Global, in vivo, and site-specific phosphorylation dynamics insignaling networks."; Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,Mann M.; Cell 127:635-648(2006). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-128 AND TYR-129, ANDMASS SPECTROMETRY. | |
| "Immunoaffinity profiling of tyrosine phosphorylation in cancercells."; Rush J., Moritz A., Lee K.A., Guo A., Goss V.L., Spek E.J., Zhang H.,Zha X.-M., Polakiewicz R.D., Comb M.J.; Nat. Biotechnol. 23:94-101(2005). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-38, AND MASSSPECTROMETRY. | |